Top Neuromodulation Devices Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Neuromodulation Devices Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Neuromodulation Devices industry players.

Neuromodulation Devices Market Competitive Landscape

The neuromodulation devices market is highly concentrated, with the top 3–4 companies holding more than 90% of the market. With a varied portfolio, great brand recognition, widespread geographic reach, and a robust distribution network, Medtronic has been able to dominate the industry. Abbott and Boston Scientific Corporation have both experienced a decline in market share over the past few years as a result of delays in the introduction of cutting-edge products in the spinal cord stimulation and other key categories.

Top Players in the Global Neuromodulation Devices Market 

  • Medtronic 
  • Synapse Biomedical 
  • Abbott Laboratories 
  • Boston Scientific Corporation 
  • LivaNova PLC 
  • Nevro Corp. 
  • NeuroSigma Inc. 
  • NeuroPace Inc. 
  • Cyberonics Inc. 
  • NDI Medical LLC 
  • NeuroMetrix Inc. 
  • NeuroVista Corporation 
  • Neuronetics Inc. 
  • BioControl Medical 
  • SPR Therapeutics 
  • MicroTransponder Inc. 
  • Soterix Medical Inc. 
  • BrainsWay Ltd. 
  • Saluda Medical Pty Ltd 

Neuromodulation Devices Market

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Neuromodulation Devices Market size was valued at USD 4000 Million in 2023 and is poised to grow from USD 4380 Million in 2024 to USD 9088.5 Million by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The neuromodulation devices market is highly concentrated, with the top 3–4 companies holding more than 90% of the market. With a varied portfolio, great brand recognition, widespread geographic reach, and a robust distribution network, Medtronic has been able to dominate the industry. Abbott and Boston Scientific Corporation have both experienced a decline in market share over the past few years as a result of delays in the introduction of cutting-edge products in the spinal cord stimulation and other key categories. 'Medtronic ', 'Synapse Biomedical ', 'Abbott Laboratories ', 'Boston Scientific Corporation ', 'LivaNova PLC ', 'Nevro Corp. ', 'NeuroSigma Inc. ', 'NeuroPace Inc. ', 'Cyberonics Inc. ', 'NDI Medical LLC ', 'NeuroMetrix Inc. ', 'NeuroVista Corporation ', 'Neuronetics Inc. ', 'BioControl Medical ', 'SPR Therapeutics ', 'MicroTransponder Inc. ', 'Soterix Medical Inc. ', 'BrainsWay Ltd. ', 'Saluda Medical Pty Ltd '

The global neuromodulation devices market is driven by a number of reasons. One of the key factors propelling the neuromodulation devices market is the increase in health issues. Due to the exceptional capacity to offer comfort in various kinds of illnesses, neuromodulation devices have grown in favor over the years for treating chronic pain, shoulder pain, headaches, and brain injuries. In addition to treating depression, digestive, and sleeping issues, neuromodulation devices are used. Therefore, the business for neuromodulation devices is being driven by the widespread use of these devices to treat a variety of disorders.

A sizable fraction of patients with long-term illnesses, such as chronic back pain, depression, epilepsy, and sleep apnea, among others, are showing signs of drug and medicine resistance. Resistance is evident in the treatment's slow progression and any outcomes that are delayed or insufficient. The market trends for neuromodulation devices are being driven by healthcare practitioners turning their attention to neurostimulation methods for the management of chronic illnesses as a result.

The neuromodulation market size in North America was at its highest level, and the region's dominance is mostly attributable to its patients' higher rates of diagnosis and treatment as well as their greater use of neuromodulation devices to treat chronic illnesses. The second-largest market share belonged to Europe. The demand for these devices is being fueled by a strong healthcare infrastructure as well as an increase in non-invasive device approvals in the region.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Neurostimulation Devices Market
Buy Now GET FREE SAMPLE
Neurology Devices Market
Buy Now GET FREE SAMPLE
Deep Brain Stimulation Devices Market
Buy Now GET FREE SAMPLE
Neurovascular Devices Market
Buy Now GET FREE SAMPLE
Electrophysiology Devices Market
Buy Now GET FREE SAMPLE
Neurorehabilitation Devices Market
Buy Now GET FREE SAMPLE
Muscle Stimulation Devices Market
Buy Now GET FREE SAMPLE
Neuroprosthetics Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Neuromodulation Devices Market
Neuromodulation Devices Market

Report ID: SQMIG35A2716

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE